Intermittent Fasting for Pancreatitis (IFPanc)
Intermittent Fasting as a Primary Means for Improving Quality of Life for Acute and Chronic Pancreatitis
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
This NA trial investigates Acute Recurrent Pancreatitis and Pancreas Disease and is currently actively recruiting participants. H. Lee Moffitt Cancer Center and Research Institute leads this study, which shows 15 recorded versions since 2026 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
May 2025 — Present [monthly]
Not Yet Recruiting NA
-
Feb 2025 — May 2025 [monthly]
Not Yet Recruiting NA
-
Dec 2024 — Feb 2025 [monthly]
Not Yet Recruiting NA
-
Oct 2024 — Dec 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
▶ Show 10 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Feb 2024 — May 2024 [monthly]
Not Yet Recruiting NA
-
Aug 2023 — Feb 2024 [monthly]
Not Yet Recruiting NA
-
Apr 2023 — Aug 2023 [monthly]
Not Yet Recruiting NA
-
Sep 2022 — Apr 2023 [monthly]
Not Yet Recruiting NA
-
Mar 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
Status: Recruiting → Not Yet Recruiting
-
Jan 2022 — Mar 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Jan 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- H. Lee Moffitt Cancer Center and Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .